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In addition to the two monomer subunits of chicken brain-type creatine kinase (B-CK, EC, 2.7.3.2), temd Bb (basic) and Ba (acidic), another 
subspecies called Bb* was identified by chromatofocussing in the presence of 8 M urea (Quest et al., [201). The latter low abundance protein species, 
isolated from tissue extracts, comigrated on 2Dgels with three minor species (Bbl-3), initially identified in immunoprecipitated, p?Jhnethionine 
labeled in vitro translation products of cDNA coding for the basic monomer Bb. During in vitro translation experiments in the presence of p2P]-y 
-ATP, Bbl-3 were labeled while phosphatase treatment eliminated these minor species. It is concluded that Bb* is identical to Bbl-3 and represents 
phosphorylated erivatives of Bb. BCK dimer populations from different issues were separated by ion-exchange chromatography and the X, 
values of the resulting fractions were determined under phosphocreatine (CP)-limiting conditions. In fractions containing only Bb and Bb* two 
kinetically different enzyme species were detected (J& values for CP = 1.6 mM and 0.8 mM), while fractions containing B-CK dimers composed 
of the major Ba and Bb monomers, but no Bb*, were homogeneous in this respect (& for CP = 1.6 mM). Phosphorylation of Bb to yield Bb* 
is concluded to reduce the K, of B-CK dimers for CP by about 50%~ This K, shift is within the range of CP concentrations found i  tissues expressing 
the B-CK isoform and may therefore be of physiological relevance. 
Phosphorylation of creatine kinase; Regulation of creatine kinase. activity; Intracellular ATP level; Energetica 
1. INTRODUCTION 
Creatine kinase (CK) belongs to a class of enzymes 
called phosphagen kinases, with representatives in 
phyla throughout the animal kingdom, which catalyze 
the reversible transfer of high-energy phosphate groups 
from ATP to guanidino compounds, termed phos- 
phagens, and vice versa [l]. The direction of the reac- 
tion favoured by CK depends on substrate concentra- 
tions, pH, on the isoforms involved and their 
subcellular location. Both, cytosolic brain-type B-CK 
and muscle-type M-CK, as well as the mitochondrial 
isoenzymes (MI-CK) readily catalyze the reaction from 
CP to ATP (the so-called ‘reverse reaction’ [2]) under in 
vitro assay conditions at the appropriate pH and 
substrate concentrations resembling the cytosolic milieu 
[3,4]. However, studies of mitochondrial respiration in 
rat heart and sea urchin sperm provide strong evidence 
that energy channeling from the mitochondria into the 
cytoplasm depends upon the preferential catalysis of 
the forward reaction by Mi-CK from ATP to CP [5,6]. 
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Enzymes catalyzing reversible reactions are generally 
not considered as targets for regulatory control [7]. 
Clearly, however, constraints imposed upon the 
mitochondrial isoform of CK by its environment deter- 
mine the direction of the phosphate-group-transfer 
reaction catalyzed [4-61. This observation emphasizes 
that the performance of enzymes catalyzing reversible 
reactions may also be regulated. Subcellular compart- 
mentation does not provide the only possibility for such 
a control. Recently, it has been demonstrated that 
enolase, an enzyme catalyzing a reversible step in the 
glycolytic pathway, is phosphorylated by protein kinase 
C (PKC) and that this posttranslational modification 
has inverse effects on both reaction directions [7]. 
Potentially, mechanisms controlling the performance 
of cytosolic CK isoenzymes together with mechanisms 
specifying their subcellular distribution could determine 
local intracellular ATP levels, for the latter nucleotide 
is not homogeneously distributed within cells, but 
rather exists in compartmentalized pools [8,9]. Micro- 
heterogeneity of ATP distribution throughout the 
cytosol, however, also can occur independent of com- 
partmentation by membranes [lo], possibly due to the 
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non-uniform distribution of ATP-generating and ATP- 
consuming reactions [l 11. On the other hand, ATP may 
fulfil multiple regulatory functions in a cell. For in- 
stance, it is an allosteric inhibitor of phosphofruc- 
tokinase, a key enzyme in the glycolytic pathway [12]. 
Furthermore, it modulates potassium channel [ 13,141 as 
well as EGF receptor [15] activity. The latter examples 
are typically membrane-bound functions. For certain 
cell types, evidence xists that the ATP concentration in 
the immediate vicinity of the cell membrane may be 
lower than that in the bulk cytoplasm [l 11. In this con- 
text B-CK, which has been found associated with 
synaptic vesicles [16,17] seemed of particular interest. 
Chicken B-CK is particularly heterogeneous, as in- 
itially revealed by 2D-gel analysis [IS]. The two major 
monomer species present, designated Ba- and Bb-CK 
[ 191, were shown to be distinct proteins [20] which are 
encoded by different mRNAs 1211. An additional 
species termed Bb* was also isolated, although its 
nature remained unresolved [20]. Some minor species 
identified in cDNA-derived in vitro translation prod- 
ucts [22,23], termed Bbl, Bb2 and Bb3 [24], are shown 
here to be phosphoproteins, which comigrate with Bb*. 
We thus addressed the question whether post-trans- 
lational modification of B-CK might influence the en- 
zymes’ kinetic properties under CP-limiting conditions, 
for limitation of CP seems to be an important 
parameter for the CK reaction and for brain energetics 
in general (see Discussion). 
Evidence is provided that the presence of Bb*, which 
can be partially enriched by chromatofocussing [20], is 
responsible for the kinetic heterogeneity observed, with 
respect to the Km for CP, in those fractions of native, 
dimeric B-CK, containing Bb* monomers. It is conclud- 
ed that chicken Bb-CK is phosphorylated and that this 
modification induces a 50% decrease in the K,,, value of 
the enzyme for CP. 
2. MATERIALS AND METHODS 
2.1. B-CK purification 
Active B-CK dimers were purified as described [19]. The final 
separation of active dimer populations was achieved on an FPLC 
MonoQ anion exchange column (Pharmacia), while B-CK monomers 
were separated on an FPLC MonoP chromatofocussing column 
(Pharmacia) in the presence of 8 M urea [20]. 
2.2. 20 gel analysis 
Two-dimensional gel analysis was carried out according to O’Far- 
rell with minor modifications as described [24]. After electrophoresis 
proteins in the gels were stained with Serva Blue G or transferred onto 
nitrocellulose [25] and reversibly stained for protein with Ponceau 
Red S. In comigration experiments with “S-labeled H4 Bb-CK 
cDNA-derived in vitro translation products [22,24], gels stained with 
Serva Blue G were subsequently prepared for fluorography using 
Amplify (Amersham). Protein positions were indicated on dry gels us- 
ing radioactive ink arrows prior to exposure to X-ray films at - 70°C. 
2.3. In vitro translation of B-CK mRNA 
Aliquots of frozen mRNA derived from in vitro transcription 
(kindly performed by T. Wirz) from a chicken Bb-CK cDNA full 
458 
length clone [22] called H4 were in vitro translated in reticulocyte 
lysate (Promega) containing [‘5S]methionine (Amersham) as describ- 
ed by the manufacturer, except for the addition of 40 U of RNasin 
(Promega) per 50 /cl assay. The translated radioactive B-CK was im- 
munoprecipitated by a specific rabbit anti-chicken B-CK antibody 
[ 161, the immune complexes collected on fiied Staphylococcus aureus 
(lg-sorb) and the precipitated radioactive CKs were coelectrophoresed 
with biochemically purified protein on 2D gels. After developing the 
autoradiogram on X-ray film, the radioactively labeled B-CK was us- 
ed as an internal standard for the identidication of B-CK subunit 
spots stained with Serva Blue G or by silver staining. 
2.4. Cotranslational phosphotylation assays 
Phosphorylation of B-CK was demonstrated by using a protein 
kinase activity residing in rabbit reticulocyte lysates (Soldati, un- 
published). Synthetic transcripts of Bb-CK were translated as describ- 
ed above except for the absence of labeled [“SS]methionine, but in- 
cluding 100&i of [“PI- y-ATP. Unfortunately, it was not possible 
to use lysates depleted of ATP and CP by gel filtration through 
Sephadex G25 to achieve a higher specific radioactivity, for lysates 
treated in such a manner have been shown to be translation incompe- 
tent [26]. Therefore, untreated lysates had to be used for cotransla- 
tional phosphorylation and incorporation of 32P yielded only very 
faint signals due to the high endogenous phosphate pools. Incubation 
was followed by immunoprecipitation [23,27] and extensive washing 
before preparation of the samples for 2D gel analysis. 
2.5. Treatment of purified B-CK fractions or in vitro translated 
Bb-CK with phosphatares 
Aliquots of translation reactions or purified Bb-CK, enriched in 
Bb* from MonoQ columns, were immunoprecipitated as described 
above. Immune complexes were collected with Protein-A or Protein- 
G Sepharose CL-4B beads (Pharmacia). The beads were then 
suspended in CIAP buffer (50 mM Tris-HCl, pH 8.0, containing 0.1 
mM EDTA) and incubated in the presence of SO-100 U of calf in- 
testinal alkaline phosphatase (CIAP, Pharmacia) at 30°C for 2 h [28]. 
The beads were then washed twice and the samples prepared for 2D 
gel analysis. 
2.6. Kinetic analysis of B-CK subspecies 
Creatine kinase activity was measured by pH-stat as described [3] 
and was expressed in IU (one international unit corresponds to 1 pmol 
of CP converted per min at pH 7.0 and 25°C). Individual fractions of 
the two B-CK peaks (type-l and type-II) obtained on MonoQ columns 
were subjected to kinetic analysis under CP-limiting conditions, but 
in the presence of excess ADP and Mg+ (3 mM and 10 mM, respec- 
tively) (for details, see [3]). Aliquots of the same fractions were 
assayed for CK activity at different CP concentrations and the initial 
slopes (v) of the different curves recorded were compared to those ob- 
tained in the presence of excess (10 mM) CP (V,,3. Results were 
linearized by plotting (V/V,,) versus (V/V,, 9 S) (modified Eadie- 
Hofstee plots). The negative slopes of these curves are numerically 
corresponding to the K,,, values for CP. Kinetically different species 
present in a mixture can be resolved by these plots. The Km values 
were only considered statistically significant if at least four indepen- 
dent values of a plot could be used for regression analysis and if the 
correlation coefficient was 0.99 or higher. Statistical comparison of 
the regression coefficients (Km) of single fractions was performed us- 
ing the two-sided Student’s t-test, the resulting error probabilities 
were indicated as P-values (P, see Table I). 
3. RESULTS 
3.1. Bb+ is a phosphorylated form of Bb-CK 
The basic main monomer (Bb), three minor species 
(Bbl, Bb2 and Bb3), the MlZ-Bb species, as well as a 
spot on the acidic side of MlZ-Bb (MlZ-Bbl) were 
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found as 3sS-labeled in vitro translation products using 
mRNA derived from the full length B-CK cDNA clone 
H4 (Fig. la). The Ml2-Bb species was shown recently 
to arise by alternative ribosomal initiation of the Bb-CK 
mRNA at methionine 12 [24]. Two minor species (Bb2 
and Bb3) were also directly visible by protein staining in 
Fig. lc, when purified B-CK protein was resolved on 
2D gels using a higher voltage and different buffers dur- 
ing isoelectric focussing than before [20] (compare 
Fig. 2). The in vitro translation products themselves are 
not visible by protein staining methods. Phosphatase 
treatment of these products eliminated Bbl, Bb2 and 
Bb3, and the spot on the acidic side of the MlZBb 
species (Fig. lb). Only Bb (large arrowhead) and Ml2 
(small arrow) remain after such treatment (Fig. lb), in- 
dicating that the minor species, Bbl-3 and the more 
acidic M12-Bbl satellite specified above, were the 
phosphorylation products of Bb- and MlZ-Bb-CK, 
IEF OH-- H+ 
b 
respectively. This was confirmed in a complementary 
experiment by in vitro translation in the presence of 
[“PI-y-ATP. Under these conditions phosphorylation 
occurred and only the above specified Bbl,2,3- and 
M 12-Bbl -CK minor monomer species were radioactive- 
ly labeled (Fig. Id). 
An additional minor component, termed Bb*, was 
found enriched in the intermediate peak fractions dur- 
ing separation of subunits on the MonoP column in the 
presence of urea [20]. This component migrated to a 
position proximal to Bb indicated by an asterisk 
(Fig. 2), coinciding with that of the three minor species 
Bbl, Bb2 and Bb3 (Fig. 1). Using the identical method 
of 2D gel electrophoresis [19] these three minor species 
were not individually resolved (Fig. 2). Recent im- 
provements of the 2D gel system for the purified protein 
indicate that Bb* contains all of these three minor 
species observed in vitro (Fig. lc). 
Fig. 1. Effect of phosphatase treatment on the migration behaviour of the Bb-CK protein subspecies and incorporation of radioactive phosphate 
into Bb-CK during in vitro translation. Immunoprecipitated in vitro translation products (reticulocyte lysate including [“S]methionine) from 
mRNA derived from synthetic H4 B-CK cDNA were resolved on 2D gels and then transferred onto nitrocelhtlose. (a,b) Autoradiograms of blotted 
proteins before (a), and after (b) treatment with CIAP. (c) A sample translated in vitro in the presence of cold amino acids, but with [“PI-Y-ATP 
after co-electrophoresis with 2 pg of purified B-CK, transfer onto nitrocellulose and protein staining with Ponceau Red S. (d) An autoradiogram 
of the sample analyzed in panel (c). stained for protein, shows incorporation of radioactive phosphate label into Bbl-. Bb2- and Bb3- as well as 
MlZ-Bbl-CK. Long arrowheads point to the main B-CK monomer species, Bb and Ba, whereas the short arrows indicate the position of the 
MlZ-Bb in vitro translation product arising from alternative initiation of translation at the methionine residue 12 [24]. 
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Fig. 2. Comigration of MonoP fractions of B-CK with in vitro translation products from a full length cDNA clone coding for Bb-CK. Samples 
from different fractions of a MonoP chromatofocussing column containing either Bb; Bb and Bb*; or Ba monomers, are shown in panels (a), (d), 
and (g) respectively, representing the corresponding 2D gels after staining for proteins with Serva Blue G. The samples were comigrated with H4 
B-CK cDNA-derived, radioactively labeled in vitro translation products. (b), (e) and (h) show the same gel1 after soaking with Amplify, drying 
and marking visible protein spot positions with arrows of radioactive ink. Large and small arrows indicate posttions of the major and minor protein 
species respectively, which were identified within the various fractions. (c), (f) and (i) show the autoradiograms on X-ray film of corresponding 
gels. The Ml2- Bb spot results from internal initiation (see Fig. 1). The spots marked by stars are phosphatase-sensitive in vitro phosphorylation 
products of Bb and MlZ-Bb (Pig. 1). Clearly, the nriched Bb* monomers migrate at the same position as the phosphatase-sensitive synthetic Bbl-3 
species (compare Fig. 1). 
3.2. Phosphorylated Bb (Bb *) is responsible for kinetic 
diversity of B-CK dimer populations in different 
tissues 
A MonoQ column profile of B-CK derived from 
chicken gizzard extracts is shown in Fig. 3, panel A. 
Similar profiles have been discussed previously for 
heart and brain derived B-CK [20]. Two major peaks of 
activity, defined as type-1 and type-II B-CK, repre- 
senting different B-CK dimer populations are typically 
resolved on this column [19]. As representative x- 
amples for type-1 B-CK and initial fractions of type-II 
B-CK, results of the kinetic analysis with respect o the 
Km for CP of fractions 43 and 47, respectively, are 
shown in Fig. 3B. Clearly, the plots of type-1 B-CK 
fractions were biphasic, while initial fractions of type-II 
B-CK were homogeneous in this respect. Since in these 
plots the negative slopes of the straight lines represent 
the Km values for CP of the respective species, it is ob- 
vious that two distinctly different kinetic species were 
present in type-1 B-CK fractions (Fig. 3B). Analysis of 
the corresponding fractions on 2D gels (Fig. 3C) show 
that, while type-II B-CK fractions contain both Ba and 
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Bb monomers, only Bb and Bb* monomers are present 
in type-1 fractions. The correlation between the 
presence of Bb* monomer and the existence of two 
kinetically different B-CK species was shown with B- 
CK derived from chicken brain, gizzard and heart 
(Table I). Only type-1 fractions contained two kinetic 
species with statistically different Km values for CP, 
whereas initial fractions of type-II peaks did not show 
this kinetic heterogeneity. The average Km values for 
CP of the two species in type-1 B-CK fractions were 0.8 
mM and 1.6 mM, while in initial type-II fractions only 
the higher K,,, value was found (Table I). These results 
show that phosphorylation product(s) of B-CK, similar 
to those found by in vitro phosphorylation experiments 
(Bb1,2, and 3, see Fig. l), are also found in vivo (Bb*, 
see Fig. 2) and that B-CK dimers containing phos- 
phorylated Bb-CK monomers (Bb*, see fig. 3C) display 
a distinctly different Km for CP (see Fig. 3B). A low Km 
value (0.8 kO.2 mM CP) was only found in fractions 
containing Bb* whereas the high Km value (1.6kO.3 
mM CP) was found in all fractions (Table I). 
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Fig. 3. Summary of the kinetic characterization of MonoQ peak fractions from gizzard extracts, yielding type-1 and type-II B-CK. (A) A represen- 
tative elution profile of gizzard B-CK on the MonoQ anion exchange chromatography column; absorbance at 280 nm (continuous line), salt concen- 
tration (dashed line) and CK-activity (shaded area) re shown. Fraction size varied; the bar length in the upper left hand comer represents an elution 
volume of 1 ml. (B) K,,, analysis results are visualized by modified Eadie-Ijofstee plots (whereby the negative slopes of the straight lines correspond 
to the Km for CP, see section 1). In type-1 B-CK fractions, represented here by fraction 43, two kinetically distinct species are present, whereas 
initial fractions of the type-II peak, represented here by fraction 47, appeared kinetically homogeneous. (C) 2D gel analysis of the B-CK-enriched 
pool loaded on the MonoQ column (I) reveals the presence of Bb, Bb* and Ba. In type-1 B-CK fractions (43) only Bb and Bb* were present, while 
initial fractions of type-II B-CK (47) contained Ba and Bb monomers. 
4. DISCUSSION 
In previous experiments designed to resolve the 
nature of the two predominant chicken B-CK monomer 
species, Ba and Bb, an additional component Bb* was 
identified [20]. Its p1 shift of about 0.1 unit of 2D gels 
with respect to Bb supported the hypothesis that this 
species may result from phosphorylation of Bb. Post- 
translational modification of brain-type CK was pro- 
posed to occur in rat brains [29], where this CK isoen- 
zyme was shown to be phosphorylated by an unknown 
protein kinase present in crude brain microtubule 
preparations. However, the role of this modification, 
which to this point has not been studied in purified en- 
zyme preparations, remained unclear. 
In this paper, Bb* is shown to comigrate on 2D gels 
with those in vitro translated products of H4 mRNA, 
termed Bbl, Bb2 and Bb3, which are phosphatase- 
sensitive and can be labeled with [32P]-y-ATP during in 
vitro translation experiments (for nomenclature of the 
different B-CK subspecies, see [24]). Therefore, Bb*, a 
B-CK component purified from tissue extracts, is iden- 
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Table I 
Kinetic analysis of single Mono Q peak fractions of B-CK from chicken brain, gizzard and heart: 
comparison of K,,, values 
Brain B-CK Gizzard B-CK 
Fraction 43 47 43 41 
Presence of Bb* + + - 
High Km [mM] 1.42 1.51 1.57 1.40 
Low Km [mM] 0.71 - 0.83 - 
PC 0.03 - 0.003 - 
Average high Km value (mM CP) = 1.6kO.3 (x=26) 
low K,,, value (mm CP) = 0.8 kO.2 (x=23) 
Heart B-CK 
22 25 
+ - 
1.75 1.57 
0.55 - 
0.001 - 
Representative set of K,,, values for CP obtained for high Km and low K,,, B-CK species, measured 
for brain, gizzard and heart-derived enzyme, are summarized in the table. Initial type-11 B-CK 
fractions (brain 47, gizzard 47, cardiac 25) containing essentially only Ba and Bb monomers in 
heterodimers, were compared with type-1 fractions (43,43 and 22, respectively), in which Bb and 
phosphorylated species thereof (Bb*) were present. The K,,, value typically found for type-II B-CK 
was identical to the high K,,, value found in type-1 B-CK fractions (average 1.6kO.3 mM CP, 
n = 26). Type-I fractions, containing the phosphorylated Bb* monomer species, exhibited a second 
kinetic species with a significant lower K,,, (average 0.8 f 0.2 mM CP, n = 23) compared to the high 
K,,, value. If in the plots of single fractions two different slopes (Km) were resolved (as for example 
in Fig. 3B. fraction 43), the statistical significance of this difference in Km was analysed by using 
the two-sided Student’s r-test; error probabilities are indicated by P-values. The resolution of B- 
CK dimers with lower K,,, values correlated with the presence of phosphorylated Bb monomers 
(Bb*) 
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tical to the three Bb-CK-derived phosphoproteins 
observed in in vitro translation experiments. The 
regular spacing of the three Bbl-3 CK spots by approx- 
imately 0.05 pH units on 2D gels is indicative of multi- 
ple phosphorylation (e.g. Fig. Id). 
Initially, Bb* protein was not resolved into different 
subspecies. However, changes in isoelectric focussing 
conditions allowed the resolution of the Bbl-3 sub- 
species in purified B-CK (Fig. lc), also supporting the 
conclusion that Bb* is identical to those three proteins 
derived from in vitro translation of H4 mRNA. The ef- 
fects of phosphatase treatment on biochemically enrich- 
ed Bb*-CK fractions characterized by 2D gel analysis 
(not shown) were considerably weaker than those 
observed from in vitro phosphorylated Bbl-3 CK 
species. Since the sensitivity of protein staining methods 
is much lower than that observed by fluorography of 
labeled proteins, higher amounts of proteins had to be 
used in those experiments, where biochemically purified 
protein was treated with phosphatases. Thus, the obser- 
vation that the spots present within Bb*-CK were only 
partially removed, are most likely due to the lower 
phosphatase to protein ratio used as compared to those 
experiments where in vitro translated radioactive 
material was treated by phosphatases (Fig. 1). 
In the final purification step of B-CK, typically two 
peaks of activity, type-1 and type-II B-CK were resolved 
(Fig. 3A). Kinetic analysis of fractions from these 
peaks under CP-limiting conditions revealed the 
presence of two distinctly different kinetic species in 
type-1 B-CK fractions, differing with respect o their K,,, 
values for CP, while the initial fractions of the type-II 
B-CK peak were homogeneous in this respect. This 
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observation was made with B-CK from several tissues 
(Table I), and the analysis of the corresponding frac- 
tions on 2D gels showed that only Bb and Bb* were 
present in the dimers of type-1 B-CK fractions, while in- 
itial fractions of the type-II B-CK peak contained 
dimers composed of Ba and Bb, but no Bb* monomers. 
Therefore, it is concluded that the presence of Bb* 
monomers in dimers results in kinetic diversity of B-CK 
populations with respect o their Km for CP. 
Only initial type-II B-CK fractions were used in this 
kinetic comparison. Subsequent fractions may contain 
a wide variety of dimer species ince at least 3 monomer 
components Bb, Bb* and Ba are present (Fig. 3C). At 
present, the possibility that Ba might also be phos- 
phorylated cannot be excluded. Because the method of 
analysis used here can only accurately resolve two 
kinetically distinct species, the interpretation of kinetic 
data from type-II B-CK peak fractions becomes highly 
ambiguous. Since Bb* comigrated on 2D gels with 
several phosphorylated species derived from Bb-CK, it 
is concluded that it is the phosphorylation of Bb-CK 
that decreases the Km of Bb-CK dimers from 1.6 to 0.8 
mM with respect o CP. Both BbBb-CK dimers (present 
in type-1 B-CK) and BaBb-CK dimers (present in type-II 
B-CK) appear to have the same high Km values (1.6 mM 
CP). The observed reduction in the K,,, from 1.6 to 0.8 
mM CP lies within a physiologically relevant range of 
CP concentrations for tissues expressing B-CK. Rat and 
human brain, for instance, contain only 3 and 5 mmol 
of CP per kg of tissue, respectively [30,32], vs 30-40 
mmol of CP per kg of rabbit skeletal muscle [3 11. In ad- 
dition, regional differences of CP content [32] as well as 
evidence for compartmentation of CP [33] and of CK 
Volume 269, number 2 FEBS LETTERS September 1990 
isoenzymes [34] were found in brain by non-invasive 
‘rP-NMR measurements and immunofluorescence 
staining, respectively. In the present work, the in vitro 
CK enzyme reaction was measured in the direction of 
ATP-synthesis, for in brain the physiologically relevant 
in vivo reaction of cytosolic B-CK is to guarantee the 
energy flux from CP to ATP, as shown directly by 
saturation transfer “P-NMR methods in intact human 
brain [32]. The importance of CP as a relevant 
physiological parameter is stressed by the fact, that the 
CP concentration of brain decreases during hypoxia or 
seizures without significant changes in ATP-levels [35]. 
Only if in addition the blood flow is decreased, CP and 
ATP levels fall towards zero rather quickly [36]. These 
data indicate that regional and possibly also subcellular 
fluctuations of CP levels can occur in brain. For these 
reasons, the effect of phosphorylation of brain-CK on 
the Km value for CP described here is thought to be 
physiologically relevant. 
In vitro phosphorylation, by PKC, of enolase, an en- 
zyme catalyzing a reversible step in the glycolytic 
pathway, has inverse effects on both directions of the 
reaction; the forward reaction is enhanced, the back- 
ward reaction inhibited by this phosphorylation [7]. 
The results presented in this paper support the conclu- 
sion of the authors mentioned above that the activity of 
enzymes catalyzing reversible reactions can also be 
modulated by post-translational modification and that 
these enzymes, therefore, are also targets of regulatory 
control. 
The mitochondrial CK isoform, bound to the outside 
of the inner mitochondrial membrane, operates essen- 
tially in one direction under physiological conditions, 
channeling energy-rich phosphate into the cytosol in the 
form of phosphocreatine [5,6,31]. Thus, it is reasonable 
to assume that subcellular localization, e.g. membrane 
association of B-CK isoforms [20,31,37] may addi- 
tionally support or enhance the kinetic differences for 
the various B-CK dimer populations measured in solu- 
tion. In this respect it is important to note that both 
cytosolic isoforms of CK, M- and B-CK, are also par- 
tially membrane-associated [ 16,17,37]. Recently, B-CK 
has been localized specifically at the plasma membrane 
of the outer segments of rod-shaped photoreceptor cells 
[37]. The regulation of CK activity by phosphorylation 
together with factors affecting intracellular partitioning 
(e.g. the association of CK with membranes which 
might be influenced by phosphorylation itself) may 
determine ATP levels at, and in the vicinity of, these 
membranes [31] and thereby directly modulate ATP- 
sensitive, membrane-associated functions [ 14,15,3 1, 
371. 
Acknowledgements: Dr. M. Walter c/o Marte and Co., Wattwil, SG 
and Dr. D. Sargent are acknowledged for help with the computation 
of kinetic parameters and Mrs. E. Zanolla for expert technical 
assistance and for photography work. Special thanks go to Dr. B. 
Schafer and T. Wirz for providing radioactively labeled in vitro 
translation products, and for communicating unpublished sequence 
information on the B-CK gene. Dr. H.P. Hassle, T. Wirz and M. 
Wyss are acknowledged for valuable discussion. This work was sup- 
ported by Swiss Natl. Science Foundation Grants 3376.086 and 
3.497.086. a grant from the Muscular Dystrophy Association of 
America to J.C.P. and an ETH graduate student scholarship to 
AFG Q. 
REFERENCES 
[l] Watts, D.C. (1971) in: Molecular Evolution 2: (Schoffeniels. E. 
ed.) North Holland Publishing Company, Amsterdam, pp. 
150-173. 
[2] Watts, D.C. (1973) in: The Enzymes 8: (Boyer, P.D. ed.) 
Academic Press, New York, pp. 384-455. 
[3] Wallimamt, T., Schliisser. T. and Eppenberger, H.M. (1984) J. 
Biol. Chem. 259, 5238-5246. 
[4] Schlegel. J., Wyss, M., Schtirch, U., Schnyder, T., Quest, A., 
Wegmann, G.. Eppenberger, H.M. and Wallimann, T. (1988) J. 
Biol. Chem. 263, 16963-16969. 
[5] Jacobus. W.E. (1985) Annu. Rev. Physiol. 47, 707-725. 
[6] Tombes, R.M. and Shapiro, B.M. (1985) Cell 41, 325-334. 
[7] Nettelblad, F.A. and Engstroem, L. (1987) FEBS Lett. 114, 
249-252. 
[B] Ugurbil, K., Holson, H. and Shulman, R.G. (1979) Proc. Natl. 
Acad. Sci. USA 76, 2227-2231. 
[9] Zahler, R., Bittl, J.A. and Ingwall, J.S. (1987) Biophys. J. 5 1, 
883-893. 
[lo] Miller, D.S. and Horowitz, S.B. (1986) J. Biol. Chem. 261, 
13911-13915. 
[ll] Jones, D.P. (1986) Am. J. Physiol. 250, C663-675. 
[12] Ramiah, A.J., Hathaway, J.A. and Atkinson, D.E. (1964) J. 
Bid. Chem. 239, 3619-3626. 
[13] Weiss, J.N. and Lamp, S.T. (1987) Science 238, 67-69. 
[14] Stanfield, P.R. (1987) Trends Biochem. Sci. 10, 335-339. 
[IS] Basu. M.. Sen-Majumadar, A., Basu, A., Murthy, U. and Dar,. 
M. (1986) J. Biol. Chem. 261, 12879-12882. 
[16] Wallimann, T., Walzthiiny, D., Wegmann, G., Moser, H., 
Eppenberger, H.M. and Barrantes, F.J. (1985) J. Cell Biol. 100, 
1063-1072. 
[17] Friedhoff, A.J. and Lemer, M.H. (1977) Life Sci. 20, 867-874. 
[18] Rosenberg, U.B., Eppenberger, H.M. and Perriard, J.C. (1981) 
Eur. J. Biochem. 116, 87-92. 
[19] Quest, A.F.G.. Eppenberger, H.M. and Wallimann, T. (1989) 
Enzyme 41, 33-42. 
[20] Quest, A.F.G, Eppenberger, H.M. and Wallimann, T. (1990) 
FEBS Lett. (in press). 
[21] Wirz, T., Hossle, J.P., Soldati, T. and Perriard. J.C. (1989) 
Experientia 45, A32. 
[22] Hossle, J.P., Rosenberg. U.B. Schaefer, B., Eppenberger, H.M. 
and Perriard, J.C. (1986) Nucleic Acid Res. 14. 1449-1463. 
[23] Schaefer, B. and Perriard, J.C. (1988) J. Cell Biol. 106, 
1161-1170. 
[24] Soldati, T., Schafer, B.W. and Perriard, J.C. (1990) J. Biol. 
Chem. 265, 4498-4506. 
[25] Towbin. H., Staehelin. T. and Gordon, J. (1979) Proc. Natl. 
Acad. Sci. USA 76, 4350-4354. 
[26] Gross. M.. Rubino, MS. and Starn, T.K. (1988) J. Biol. Chem. 
263. 1248612492. 
[27] Perriard. J.C., Caravatti, M.. Perriard, E.R. and Eppenberger, 
H.M. (1978) Arch. B&hem. Biophys. 191, 90-100. 
1281 Sorger, P.K. and Pelham, H.R.B (1988) Cell 54, 855-864. 
[29] Mahadevan, L.C., Whatley, S.A., Leung, T.K.C. and Lim, L. 
(1984) B&hem. J. 222, 139-144. 
(301 Iyengar, R.M. (1984) J. Muscle Res. Cell Motil. 5, 527-534. 
[31] Wallimann, T., Schnyder, T.. Schlegel, J., Wyss, M., 
Wegmann. G., Rossi, A.M., Hemmer, W., Eppenberger, H.M. 
and Quest, A.F.G. (1989) in: Progress in Clinical and Biological 
Research. vol. 315, Muscle Energetics. Liss, New York, pp. 
159-176. 
463 
Volume 269, number 2 FEBS LETTERS September 1990 
[32] Cadoux-Hudson, T.A., Blackledge, M.J. and Radda, G.K. 
(1989) FASEB J. 3. 2660-2666. 
[33] Holtxman, D., McFarland, E., Moerland, T., Koutcher, J., 
Kushmerick, M. and Neuringer, L. (1989) Brain Res. 483,68-77. 
[34] Scalabrini, C., Hemmer, W. and Wallimann, T. (1989) 
Experientia, 45, A19. 
[35] Prichard, J.W., Alger, J.R., Behar, K.L., Petroff, O.A.C. and 
Shulman, R.G. (1985) Proc. Natl. Acad. Sci. USA 80, 
2748-2751. 
[36] Thulborn, K.R., Des Boulay, B.M., Duchen, L. W. and Radda, 
G. (1982) J. Cereb. Blood Flow 2, 199-306. 
[37] Hemmer, W., Quest, A.F.G.. Zanolla, E., Eppenberger, H.M. 
and Wallimann. T. (1989) Experientia 45, A70. 
